Robuta

https://news.antiwar.com/2026/03/31/us-israeli-strikes-in-iran-hit-orphanage-cancer-drug-facility-religious-site-and-more-residential-buildings/ US-Israeli Strikes in Iran Hit Orphanage, Cancer Drug Facility, Religious Site, and More... US-Israeli strikes continue to pound civilian targets in Iran, hitting an orphanage, a cancer drug facility, a religious site, and more residential buildings... us israeli strikesiran hitcancer drugorphanagefacility https://www.newswise.com/articles/bone-cancer-drug-clinical-trial-for-children-young-adults-launches Bone Cancer Drug Clinical Trial for Children, Young Adults Launches | Newswise Apr 15, 2026 - A new clinical trial led by the Penn State College of Medicine-based Beat Childhood Cancer Research Consortium will evaluate whether the drug eflornithine... bone cancer drugchildren young adultsclinical triallaunchesnewswise https://www.hurriyetdailynews.com/turkiyes-first-homegrown-cancer-drug-clears-phase-1-trials-220696 Türkiye’s first homegrown cancer drug clears phase 1 trials - Türkiye News Apr 7, 2026 - Türkiye has reached a milestone in pharmaceutical research, with the country’s first domestically developed drug candidate successfully completing Phase 1... first homegrowncancer drugphase 1clearstrials https://www.ornl.gov/news/neutrons-settle-40-year-debate-enzyme-cancer-drug-design Neutrons settle 40-year debate on enzyme for cancer drug design 40 yearcancer drugneutronssettledebate https://www.denverpost.com/2026/03/24/biotech-billionaire-fda/ FDA flags misleading claims for cancer drug by billionaire Soon-Shiong Mar 24, 2026 - Federal health officials have issued a warning about controversial statements made by biotech billionaire Dr. Patrick Soon-Shiong about one of his company fda flagsmisleading claimscancer drugsoon shiongbillionaire https://medcitynews.com/2026/04/obsidian-galera-merger-til-cell-therapy-cancer-melanoma-grtx-obx/ Obsidian, Galera Merger Comes With $350M Infusion for Cancer Drug Trials - MedCity News Apr 19, 2026 - Obsidian Therapeutics aims to show its TIL cell therapy has advantages over an Iovance Biotherapeutics TIL therapy marketed for treating melanoma. Obsidian’s... cancer drugmedcity newsobsidiangaleramerger https://www.technologynetworks.com/applied-sciences/news/dna-based-smart-drugs-designed-to-fight-cancer-411317 Smart Cancer Drug System Uses DNA to Target Tumors Precisely | Technology Networks Apr 2, 2026 - UNIGE scientists have developed a smart cancer drug that uses synthetic DNA to identify tumor cells with precision, enabling highly targeted treatment. cancer druguses dnatechnology networkssmartsystem https://euperspectives.eu/2026/04/cancer-drug-shortages-expose-europes-dangerous-dependence-on-a-few-global-suppliers/ Cancer drug shortages expose Europe’s dangerous dependence on a few global suppliers - EU... Shortages of two key chemotherapy medicines are affecting countries across Europe. Regulators warn disruptions could last through 2026. cancer drugglobal suppliersshortagesexposedangerous https://www.biospace.com/drug-development/ideaya-and-serviers-eye-cancer-drug-heads-to-fda-after-delivering-best-in-class-efficacy IDEAYA and Servier’s eye cancer drug heads to FDA after delivering ‘best in class’ efficacy -... Apr 13, 2026 - Darovasertib, in combination with crizotinib, more than doubled progression-free survival in a registrational trial, leading Truist analysts to declare a... eye cancerideayadrugheadsfda https://www.biopharmadive.com/news/roche-igntya-acquire-deal-lung-cancer/513716/ Roche drops $1.7B for Ignyta and its lung cancer drug | BioPharma Dive Interim data from October found objective response rates as high as 78% in NSCLC patients with a type of gene rearrangement who took Ignyta's entrectinib. drug biopharma divedrops 1lung cancerroche7b https://reutersbest.com/merck-rivals-eye-deal-for-inhibrx-experimental-cancer-drug-tied-to-keytruda-sources-say/ Merck, rivals eye deal for Inhibrx experimental cancer drug tied to Keytruda, sources say | Reuters... sources say reuterscancer drugmerckrivalseye https://www.news-medical.net/news/20260416/Why-AI-is-becoming-a-powerful-tool-in-cancer-drug-discovery.aspx Why AI is becoming a powerful tool in cancer drug discovery This Perspective reviews how AI is moving drug discovery from long, costly experimental pipelines toward earlier clinical translation, with an AI-designed TNIK... cancer drug discoverypowerful toolaibecoming https://www.broadinstitute.org/news/bayer-broad-expand-partnership-advance-cancer-drug-discovery-research Bayer, Broad expand partnership to advance cancer drug discovery research | Broad Institute Broad Institute is a multidisciplinary community of researchers on a mission to improve human health. cancer drug discoveryexpand partnershipresearch institutebayerbroad https://www.psu.edu:443/news/medicine/story/bone-cancer-drug-clinical-trial-children-young-adults-launches Bone cancer drug clinical trial for children, young adults launches | Penn State University Apr 16, 2026 - A new clinical trial led by the Penn State College of Medicine-based Beat Childhood Cancer Research Consortium will evaluate whether the drug eflornithine can... bone cancer drugchildren young adultspenn state universityclinical triallaunches https://healthcare-in-europe.com/en/news/map-cancer-drug-uptake-in-living-cells.html New technique maps cancer drug uptake inside living cells • healthcare-in-europe.com The technique could be extended beyond cancer research to study how any metal-based drug or toxic substance distributes inside living cells. inside living cellsnew techniquecancer drugmapsuptake https://news.ohsu.edu/file/20251216-aml-drug-4?action= OHSU researchers find breast cancer drug boosts leukemia treatment |OHSU News researchers findbreast cancerleukemia treatmentohsudrug https://xraised.com/videos/crb091-a-groundbreaking-tumor-agnostic-cancer-drug-with-fast-track-potential/ CRB091: A Groundbreaking, Tumor-Agnostic Cancer Drug with Fast-Track Potential - xraised Jun 8, 2025 - Kari Sarvanto, founder of Cancer Research and Biotechnology AG, introduces CRB091—a next-gen cancer therapy with proven safety, tumor-agnostic efficacy, and... cancer drugfast trackgroundbreakingtumoragnostic https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/cancer-drug-makers-seek-50-price-hike-as-platinum-surge-hits-production-viability/articleshow/130046021.cms Cancer drug makers seek 50% price hike as platinum surge hits production viability - The Economic... Apr 6, 2026 - Local drug manufacturers are struggling to produce essential cancer medicines like carboplatin and cisplatin due to a significant surge in platinum prices.... cancer drug50 pricehits productionmakersseek https://www.ctvnews.ca/health/article/us-judge-rejects-bayer-bid-to-block-johnson-johnson-prostate-cancer-drug-claims/ Bayer's bid to block Johnson & Johnson cancer drug rejected in U.S. cancer drugbayerbidblockjohnson https://interestingengineering.com/ai-robotics/snail-inspired-robots-cancer-drug-delivery Snail-inspired robots target precise bowel cancer drug delivery Mar 27, 2026 - Snail-inspired robots aim to deliver cancer drugs precisely to tumors, reducing side effects and improving outcomes. bowel cancerdrug deliverysnailinspiredrobots https://www.click2houston.com/business/2026/03/24/fda-flags-misleading-claims-for-cancer-drug-by-biotech-billionaire-patrick-soon-shiong/ FDA flags misleading claims for cancer drug by biotech billionaire Patrick Soon-Shiong Mar 24, 2026 - Federal health officials have issued a warning about controversial statements made by biotech billionaire Dr. Patrick Soon-Shiong about one of his company's... patrick soon shiongfda flagsmisleading claimscancer drugbiotech https://pennstatehealthnews.org/2026/04/bone-cancer-drug-clinical-trial-for-children-young-adults-launches/ Bone cancer drug clinical trial for children, young adults launches - Penn State Health News Apr 16, 2026 - A new clinical trial led by the Penn State College of Medicine-based Beat Childhood Cancer Research Consortium will evaluate whether the drug eflornithine… bone cancer drugchildren young adultspenn state healthclinical triallaunches https://www.biopharmadive.com/news/merck-welireg-1l-renal-cell-carcinoma-study-results/818093/ Merck’s fast-ascending kidney cancer drug hits a setback | BioPharma Dive Welireg’s failure in first-line kidney cancer removes a blockbuster opportunity and could leave an opening for a rival drug from Arcus Biosciences, analysts... kidney cancerbiopharma divefastascendingdrug https://www.pennstatehealth.org/patient-stories/new-cancer-drug-leads-family-penn-state-health-golisano-childrens-hospital New cancer drug leads family to Penn State Health Golisano Children’s Hospital | Penn State Health penn state healthnew cancerdrug leadsfamilygolisano https://www.lsu.edu/working-for-louisiana/news/2022/09-ai-cancer.php Research Team Builds AI Cancer Drug Discovery Engine An interdisciplinary LSU research team with members in the School of Veterinary Medicine, College of Science, College of Engineering, and the Center for... cancer drug discoveryresearch teambuilds aiengine https://pulse.mk.co.kr/news/english/12006077 LG Chem secures novel cancer drug candidate from U.S. biotech - 매일경제 영문뉴스 펄스(Pulse) lg chemcancer drugsecuresnovelcandidate https://www.biopharmadive.com/news/revolution-pancreatic-cancer-ras-drug-results/817300/ Revolution pancreatic cancer drug nearly doubles survival in key trial | BioPharma Dive The subject of buyout rumors this year, Revolution posted Phase 3 results one analyst called a “game changer” in a tough-to-treat tumor. trial biopharma divepancreatic cancernearly doublesrevolutiondrug https://www.statnews.com/2026/04/14/ben-sasse-revolution-medicines-daraxonrasib-clinical-trial/ Ben Sasse grateful to be in Rev Med's pancreatic cancer drug trial Apr 17, 2026 - Q-and-A with former Sen. Ben Sasse, a participant in Revolution Medicines' clinical trial for daraxonrasib, a promising new drug for pancreatic cancer. ben sassepancreatic cancerdrug trialgratefulrev https://archive.org/details/pankajoudhiaoncancerdruginteractions23419 Pankaj Oudhia On Cancer Drug Interactions 23419 : Pankaj Oudhia : Free Download, Borrow, and... A part of series titled Pankaj Oudhia on cancer drug interactions 1 to 50,000. For related queries write at pankajoudhia@gmail.com free download borrowcancer drugpankajinteractions https://www.rcsb.org/news/68e80b61829c3fea8eaf3958 Impact of PDB Structures on Anti-Cancer Drug Approvals Open access to PDB data facilitates discovery and development of life saving drugs. pdb structuresanti cancerdrug approvalsimpact https://endpoints.news/ipsen-pulls-cancer-drug-tazverik-from-market-over-safety-risks/ Ipsen pulls cancer drug Tazverik from market over safety risks The committee reported cases of hematologic malignancies in a follicular lymphoma study dubbed SYMPHONY-1. cancer drugsafety risksipsenpullsmarket https://us.movember.com/story/view/id/12267/game-changing-cancer-drug-one-step-closer-to-reaching-prostate-cancer-patients?tag=prostate-cancer Movember - Story - Game-changing cancer drug one step closer to reaching prostate cancer patients Movember is the leading global organisation committed to changing the face of men’s health. one step closermovember storygame changingcancer drugreaching https://www.news-medical.net/life-sciences/Nanostructured-toxins-for-the-selective-destruction-of-drug-resistant-human-CXCR4style2b-colorectal-cancer-stem-cells.aspx Toxins for drug-resistant human CXCR4+ colorectal cancer stem cells A novel toxin-based nanoparticle drug specifically is designed to attack colorectal cancer stem cells with overexpression of the chemokine receptor CXCR4. drug resistantcolorectal cancerstem cellstoxinshuman https://www.psiquantum.com/news-import/ncc-japan-partnership-announcement PsiQuantum and National Cancer Center Japan Announce New Strategic Partnership to Accelerate Drug... Mar 12, 2026 - PALO ALTO, Calif. – PsiQuantum announced today that the company has signed a collaborative research agreement with the National Cancer Center Japan, a leading... national cancer centernew strategic partnershipaccelerate drugpsiquantumjapan https://www.statnews.com/pharmalot/2026/04/13/revolution-pancreatic-cancer-pill-fda-rejects-replimune-cancer-drug/ Pharmalittle: Pancreas cancer data strong, Replimune drug rejected| STAT Apr 13, 2026 - The FDA rejected — again — an experimental treatment for advanced skin cancer developed by Replimune, which has become a flashpoint. pancreas cancerdrug rejectedpharmalittledatastrong https://www.cureus.com/articles/473502 Drug Utilization and Safety Profile of Intravenous Iron Isomaltoside 1000 in Cancer Patients With... Background: Iron deficiency anemia (IDA) is a persistent complication in cancer patients and may result from chronic inflammation, poor nutritional intake, and... drug utilizationcancer patientssafetyprofileintravenous https://news.cancerresearchuk.org/2026/04/21/data-science-has-ai-solved-drug-discovery/ Data science: has AI solved drug discovery? - Cancer Research UK - Cancer News Apr 24, 2026 - Spoiler-alert… no. At least not yet. But it is revolutionising the field in incredible ways. Bissan Al-Lazikani gets into where we are with AI and drug... cancer research ukdata sciencedrug discoveryaisolved https://www.newswise.com/articles/study-diabetes-drug-metformin-may-echo-the-benefits-of-exercise-in-prostate-cancer-care Study: Diabetes Drug, Metformin, May Echo the Benefits of Exercise in Prostate Cancer Care |... Mar 31, 2026 - The diabetes drug, metformin, may mimic key benefits of exercise in prostate cancer patients, raising a molecule linked to weight and energy control even... prostate cancer carediabetes drugstudymetforminmay https://sciencedaily.com/releases/2026/04/260402042744.htm Scientists create “smart” DNA drug that targets cancer cells with extreme precision | ScienceDaily Scientists have created a programmable drug system that can zero in on cancer cells with unprecedented accuracy. Built from synthetic DNA, it only activates... scientists createcancer cellsdnadrugtargets https://www.cancerresearchuk.org/for-researchers/our-research-strategy/research-translation-and-drug-development Research translation and drug development | Cancer Research UK We're accelerating the discovery and development of new treatments, tools and diagnostics through our strategic research and translational partnerships. research translationdrug developmentcancer uk https://whitleylawfirm.com/raleigh/dangerous-drug-lawyer/belvig/ Raleigh Belviq Lawyer | Anti-Obesity Drug Linked to Cases of Cancer Feb 20, 2026 - If you or someone you know has taken Lorcaserin and been diagnosed with cancer, you should speak with a Raleigh Belviq lawyer as soon as possible. anti obesitydrug linkedraleighlawyercases https://link.springer.com/collections/ghjaihbded?error=cookies_not_supported&code=59a010b1-30ad-43b4-a834-66ad82168ec5 Targeting Drug Resistance in Cancer Therapy | Springer Nature Link The collection examines the multifaceted challenge of drug resistance in cancer treatment. It investigates molecular drivers of resistance, including genetic... therapy springer naturetargeting drugresistancecancer https://www.clocate.com/international-cancer-research-and-drug-discovery-conference-i-cancer-congress/99629/ International Cancer Research and Drug Discovery Conference (i-Cancer Congress), 16-17 Jul 2026 |... International Cancer Research and Drug Discovery Conference (i-Cancer Congress), 16-17 Jul 2026, Toronto, Canada, organized by Exponet Events. Find conference... cancer researchdrug discovery16 17jul 2026international https://spirea.co.uk/ Spirea – Elevating the Therapeutic Potential of Antibody-Drug Conjugates in Cancer and Beyond antibody drug conjugatestherapeutic potentialspireaelevatingcancer https://www.dailymail.com/health/article-15762903/British-cancer-patients-set-face-drug-shortages-WEEKS-Iran-war-sends-prices-soaring-warn-pharmacies.html British cancer patients set to face drug shortages within WEEKS as Iran war sends prices soaring,... Apr 24, 2026 - British cancer patients could be left without life-saving drugs as medicine prices skyrocket due to the war in Iran, experts have warned. iran war sendscancer patientsdrug shortageswithin weeksprices soaring https://www.biopharmadive.com/news/revolution-aacr-2026-daraxonrasib-pancreatic-cancer-results/818173/ Revolution drug shows promise in early pancreatic cancer | BioPharma Dive The findings build on data suggesting Revolution’s therapy could upend treatment for a notoriously tough-to-treat tumor and generate billions in sales. drug shows promiseearly pancreatic cancerbiopharma diverevolution https://www.livescience.com/health/cancer/new-triple-drug-treatment-stops-pancreatic-cancer-in-its-tracks-a-mouse-study-finds New triple-drug treatment stops pancreatic cancer in its tracks, a mouse study finds | Live Science Jan 30, 2026 - By targeting three key growth pathways at once, researchers eliminated pancreatic tumors in multiple mouse models and prevented the cancer from returning, a... study finds livenew tripledrug treatmentpancreatic cancerstops https://www.takarabio.com/applications/cancer-research/gene-editing-for-cancer-therapydrug-discovery Gene editing for cancer therapy/drug discovery Gene editing is a powerful tool for cancer research and Takara Bio's gene editing portfolio can help every step of the way. gene editingcancer therapydrug discovery https://sumlineknowledgebase.com/sum-breast-cancer-cell-lines/sum-149-home-page/sum-149-differential-drug-sensitivity-data/ SUM-149 Differential Drug Sensitivity Data - The SUM Cancer Cell Line Knowledge Base (SLKBase) Oct 19, 2020 - The data shown in the bar graph were published by Heiser et al. in 2012 (Heiser et al, Proc. Natl. Acad. Sci. USA, 109 (8) 2724-2729, 2012.) The data are the... cancer cell lineknowledge base slkbasesum149differential https://www.broadinstitute.org/news/study-finds-biomarkers-drug-targets-risk-factors-most-common-form-lung-cancer Study finds biomarkers, drug targets, risk factors for most common form of lung cancer | Broad... Large analysis of genes and proteins in lung adenocarcinoma points to possible new diagnostic and treatment approaches, and also reveals signatures of chemical... study findsdrug targetsrisk factorslung cancerbiomarkers https://www.broadinstitute.org/news/new-drug-triggers-rapid-cell-death-cancer-models New drug triggers rapid cell death in cancer models | Broad Institute BRD-810 inhibits the MCL1 protein and reactivates apoptosis in tumor cells, displaying therapeutic potential in animal models. new drugcell deathcancer modelsbroad institutetriggers https://www.cancerresearchuk.org/for-researchers/how-we-deliver-research/our-research-infrastructure/centre-for-drug-development Centre for Drug Development (CDD) | Cancer Research UK The Centre for Drug Development brings drug development expertise together with innovators in science and medicine to deliver early-phase clinical trials. cancer research ukdrug developmentcentrecdd https://ufhealth.org/news/2026/new-drug-delivery-mechanism-could-aid-breast-cancer-treatment New drug delivery mechanism could aid breast cancer treatment - UF Health GAINESVILLE, Fla. — In a study published in the Journal of Extracellular Vesicles, scientists from the UF Health Cancer Institute have found a way to make… breast cancer treatmentnew drugcould aiduf healthdelivery https://www.foxnews.com/health/pancreatic-cancer-patient-ben-sasse-sees-massive-tumor-reduction-experimental-drug Experimental drug doubles survival in metastatic pancreatic cancer trial | Fox News Apr 28, 2026 - Former Nebraska Sen. Ben Sasse said the experimental drug daraxonrasib has dramatically reduced his pancreatic tumors. Trial data suggests the therapy doubles... trial fox newsexperimental drugdoubles survivalpancreatic cancermetastatic https://cancer.illinois.edu/researchers-develop-new-way-to-turn-red-blood-cells-into-long-lasting-drug-carriers/ Researchers Develop New Way to Turn Red Blood Cells into Long-Lasting Drug Carriers | Cancer Center... researchers develop newturn redblood cellslong lastingcancer center https://www.cancertherapyadvisor.com/ Cancer Management & Treatment | Cancer Research & Drug Trials Jan 27, 2026 - Cancer Therapy Advisor offers the latest cancer management and treatment info, cancer research news, and more for oncologists and medical professionals. cancer managementtreatment researchdrug trials